Dr. Garnett holds a D.D.S. from the New York University and has received graduate education in Chemistry and Biochemistry. He has had research laboratories at the Central Islip State Hospital, Waldemar Medical Research Foundation, Northport Veterans' Administration Medical Center, and the High Technology Incubator of The State University of New York at Stony Brook.
Dr. Merrill Garnett
A doctor and research chemist, is the founder and CEO of Garnett McKeen Laboratory, Inc. in Stony Brook, New York. He is the inventor and recipient of three U.S. patents for POLY-MVA™.
Dr. Garnett's principle laboratory discoveries reveal the presence of corollary dynamics of the genetic code by which specific DNA coded segments and cell membranes exchange ultra-low frequency sinusoidal electrical currents. According to his theory, these pulsed currents are the basis of all physiological pulses and determine the polarization, charge and folding of enzymes, nucleic acids and membrane phospholipids. The restoration of these charge transfer pathways form the basis of several new methods of medicinal management. Garnett refers to this area of research as Electrogenetics.
What is Electrogenetics?
Electrogenetics is the basis for designing medicines that can short circuit the electrical charges in cancer cells and produce their selective electrocution. Electrogenetics describes the energy requirements, energy exchanges, and electronic circuits, which allow gene reactions to occur in the living state.
Investigators at the University of Utah and Columbia University have collaborated in studies of his compound, DNA Reductase. This is the first non-toxic chemotherapeutic agent, a liquid crystal complex of palladium and lipoic acid.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Toll Free 1-866-991-9942
